Cargando…
Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression
Decitabine (DAC), a DNA methyltransferase (DNMT) inhibitor, is tested in combination with conventional anticancer drugs as a treatment option for various solid tumors. Although epigenome modulation provides a promising avenue in treating resistant cancer types, more studies are required to evaluate...
Autores principales: | Buocikova, Verona, Tyciakova, Silvia, Pilalis, Eleftherios, Mastrokalou, Chara, Urbanova, Maria, Matuskova, Miroslava, Demkova, Lucia, Medova, Veronika, Longhin, Eleonora Marta, Rundén-Pran, Elise, Dusinska, Maria, Rios-Mondragon, Ivan, Cimpan, Mihaela Roxana, Gabelova, Alena, Soltysova, Andrea, Smolkova, Bozena, Chatziioannou, Aristotelis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585938/ https://www.ncbi.nlm.nih.gov/pubmed/36278182 http://dx.doi.org/10.3389/fphar.2022.991751 |
Ejemplares similares
-
Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives
por: Buocikova, Verona, et al.
Publicado: (2020) -
The alamar blue assay in the context of safety testing of nanomaterials
por: Longhin, Eleonora Marta, et al.
Publicado: (2022) -
The colony forming efficiency assay for toxicity testing of nanomaterials—Modifications for higher-throughput
por: Rundén-Pran, Elise, et al.
Publicado: (2022) -
Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy
por: Soltysova, Andrea, et al.
Publicado: (2020) -
Erratum to: Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
por: Skolekova, Svetlana, et al.
Publicado: (2016)